Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP5

MIVASE Résumé de rapport

Project ID: QLG1-CT-2000-01801
Financé au titre de: FP5-LIFE QUALITY
Pays: United Kingdom

Antibody effective in inhibiting extracellular acidification

Antibodies have been developed which show high specificity towards the specific proteins expressed in osteoblasts and a range of cancer cells. One of these antibodies can inhibit bone resorption due to osteoclasts and the migration of metastatic cancer cells in culture. Patents covering these discoveries are in the process of submission. The results have clear potential for immunotherapeutic approaches to osteoporosis and cancer.

Informations connexes

Reported by

University of Leeds
School of Biochemistry & Microbiology, University of Leeds
LS2 9JT Leeds
United Kingdom
See on map